Surgery Partners EBITDA Margin 2013-2024 | SGRY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Surgery Partners (SGRY) over the last 10 years. The current EBITDA margin for Surgery Partners as of September 30, 2024 is .
Surgery Partners EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $2.98B $0.49B 16.39%
2024-06-30 $2.89B $0.49B 16.90%
2024-03-31 $2.79B $0.49B 17.50%
2023-12-31 $2.74B $0.46B 16.77%
2023-09-30 $2.72B $0.45B 16.61%
2023-06-30 $2.66B $0.44B 16.60%
2023-03-31 $2.61B $0.42B 16.25%
2022-12-31 $2.54B $0.47B 18.59%
2022-09-30 $2.44B $0.48B 19.82%
2022-06-30 $2.38B $0.47B 19.75%
2022-03-31 $2.31B $0.45B 19.54%
2021-12-31 $2.22B $0.41B 18.57%
2021-09-30 $2.16B $0.40B 18.41%
2021-06-30 $2.10B $0.35B 16.77%
2021-03-31 $1.93B $0.34B 17.35%
2020-12-31 $1.86B $0.29B 15.54%
2020-09-30 $1.83B $0.26B 14.22%
2020-06-30 $1.79B $0.29B 16.47%
2020-03-31 $1.86B $0.30B 16.17%
2019-12-31 $1.83B $0.32B 17.64%
2019-09-30 $1.81B $0.20B 10.86%
2019-06-30 $1.79B $0.18B 10.08%
2019-03-31 $1.78B $0.17B 9.34%
2018-12-31 $1.77B $0.16B 8.75%
2018-09-30 $1.74B $0.29B 16.49%
2018-06-30 $1.61B $0.23B 14.50%
2018-03-31 $1.47B $0.22B 14.95%
2017-12-31 $1.34B $0.22B 16.12%
2017-09-30 $1.19B $0.19B 16.10%
2017-06-30 $1.16B $0.24B 20.29%
2017-03-31 $1.17B $0.25B 21.63%
2016-12-31 $1.15B $0.24B 21.12%
2016-09-30 $1.10B $0.20B 17.95%
2016-06-30 $1.06B $0.20B 18.68%
2016-03-31 $1.00B $0.19B 18.54%
2015-12-31 $0.96B $0.19B 19.69%
2015-06-30 $0.53B $0.12B 22.70%
Sector Industry Market Cap Revenue
Medical Medical Services $2.892B $2.743B
Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00